Document and Entity Information
Document and Entity Information | Jun. 15, 2023 |
Cover [Abstract] | |
Document Type | 8-K |
Entity Ex Transition Period | false |
Amendment Flag | false |
Document Period End Date | Jun. 15, 2023 |
Entity Registrant Name | IMPEL PHARMACEUTICALS INC. |
Entity Central Index Key | 0001445499 |
Entity Emerging Growth Company | true |
Security12b Title | Common Stock, $0.001 Par Value Per Share |
Trading Symbol | IMPL |
Security Exchange Name | NASDAQ |
Entity File Number | 001-40353 |
Entity Incorporation State Country Code | DE |
Entity Tax Identification Number | 26-3058238 |
Entity Address Address Line1 | 201 Elliott Avenue West |
Entity Address, Address Line Two | Suite 260 |
Entity Address City Or Town | Seattle |
Entity Address State Or Province | WA |
Entity Address Postal Zip Code | 98119 |
City Area Code | 206 |
Local Phone Number | 568-1466 |
Entity Information, Former Legal or Registered Name | Impel NeuroPharma, Inc. |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |